Send feedback

ENG p.Ser615Leu

c.1844C>T · rs148002300 · VCV161229

Likely benign Expert panel
Classification
Likely benign
ClinVar
Review
Expert panel ★★★☆
ClinVar · 16 submitters
AlphaMissense
likely benign
0.0707 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.244%, nfe)
Missense predictors
1/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
telangiectasia, hereditary hemorrhagic, type 1

ClinGen expert panel — Hereditary Hemorrhagic Telangiectasia VCEP

Likely Benign for telangiectasia, hereditary hemorrhagic, type 1. Applied ACMG criteria (verbatim):

BS1 BP5 BS3_Supporting

Curation rationale (ClinGen, verbatim)

The NM_001114753.3: c.1844C>T variant in ENG is a missense variant predicted to cause substitution of serine by leucine at amino acid 615 (p.Ser615Leu). The filtering allele frequency (the lower threshold of the 95% CI of 285/115780) of the c.1844C>T variant in ENG is 0.002284 for European (non-Finnish) chromosomes by gnomAD v2.1.1, which is higher than the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel threshold (>0.002) for BS1, and therefore meets this criterion (BS1). This variant has been observed in 1 patient with an alternate molecular basis for disease (patient also carries a likely pathogenic/pathogenic ACVRL1 variant) (BP5; PMID: 15712270). The computational predictor REVEL gives a score of 0.188, which is neither above nor below the thresholds predicting a damaging or benign impact on ENG function. However, cellular assays in NIH-3T3 cells showed that BMP9 binding and BMP9 response were all normal, indicating that this variant does not impact protein function (BS3_Supporting; PMID: 25312062, 22022569). In summary, this variant meets the criteria to be classified as likely benign for autosomal dominant hereditary hemorrhagic telangiectasia based on the ACMG/AMP criteria applied, as specified by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel: BS1, BP5, BS3_Supporting (specification version 1.0.0; 1/4/2024).

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.0707likely benign
REVEL0.188benign-leaning
SaProtLLR -10.41damaging
⇒ SaProt calls this damaging; AlphaMissense and REVEL do not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 4.5GERP -0.23, phastCons 1
Regional constrainto/e 0.86unconstrained · MANE · 39 kb · p 5.2e-05 · regional, not allelic
Overall
CADD21.2PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.244% European (non-Finnish) · 2,866/1,173,790 alleles
Filtering AF 0.237% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.234%
Overall 0.2% 3,197/1,599,576 alleles · rare
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.244% 410
Finnishnot grpmax-eligible 0.148% 675
Remaining individualsnot grpmax-eligible 0.134% 747
South Asian 0.0925% 1,081
African / African-American 0.048% 2,082
Admixed American 0.0451% 2,218
East Asian 0.0248% 4,033
Middle Eastern 0.0167% 5,982

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ENG
Protein
p.Ser615Leu
Coding
c.1844C>T
MANE Select
NM_001114753
dbSNP
rs148002300
Type
single nucleotide variant
Location
chr9:127815951 (GRCh38)
Gene constraint
LOEUF 0.374 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 80.84 · 3 PDB
Residue 615
a UniProt-annotated variant site (in)
Full ENG gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

telangiectasia, hereditary hemorrhagic, type 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: hereditary hemorrhagic telangiectasia

For Hereditary hemorrhagic telangiectasia (Orphanet):

Inheritance
Autosomal dominant
Onset
All ages
Prevalence
1-5 / 10 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/eng-p-ser615leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown